155 related articles for article (PubMed ID: 37870586)
1. New opportunities for dosimetric approach in patients with differentiated thyroid cancer.
Piscopo L; Zampella E; Klain M
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):330-331. PubMed ID: 37870586
[No Abstract] [Full Text] [Related]
2. Total thyroidectomy and synchronous video assisted lung metastasectomy in differentiated thyroid carcinoma.
De Toma G; Nicolanti V; Plocco M; Cavallaro G; Letizia C; D'Erasmo E
J Exp Clin Cancer Res; 1999 Jun; 18(2):147-50. PubMed ID: 10464700
[No Abstract] [Full Text] [Related]
3. Dosimetric approach to
Görtan FA; Yüksel AÖ; Gülaldı NCM; Coşkun N; Akça CDK
Hell J Nucl Med; 2022; 25(3):260-268. PubMed ID: 36507882
[TBL] [Abstract][Full Text] [Related]
4. Differentiated thyroid cancer: lobectomy and radioiodine, a treatment suitable for all cases?
Allan E; Owens SE; Waller ML
Nucl Med Commun; 1999 Nov; 20(11):983-9. PubMed ID: 10572907
[TBL] [Abstract][Full Text] [Related]
5. The combined evaluation of clinical and biochemical data in management of patients with differentiated thyroid cancer.
Volpe F; Piscopo L
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):230-232. PubMed ID: 37552368
[No Abstract] [Full Text] [Related]
6. Multistage high-dose I-131 treatment for a nonthyroidectomized patient with metastatic differentiated thyroid cancer.
Ahn BC; Lee SW; Lee J
Clin Nucl Med; 2011 Dec; 36(12):e224-7. PubMed ID: 22064117
[No Abstract] [Full Text] [Related]
7. [Carcinoma of the thyroid in childhood].
Sgro M; Spreafico GL; Colombo L; Musazzi R
Minerva Chir; 1979 Jan 15-31; 34(1-2):63-72. PubMed ID: 481764
[No Abstract] [Full Text] [Related]
8. Differentiated thyroid cancer: radioiodine following lobectomy - a clinical feasibility study.
Hoyes KP; Owens SE; Millns MM; Allan E
Nucl Med Commun; 2004 Mar; 25(3):245-51. PubMed ID: 15094442
[TBL] [Abstract][Full Text] [Related]
9. Differentiated thyroid carcinoma: Incremental diagnostic value of
Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
[TBL] [Abstract][Full Text] [Related]
10. Radioiodine lobar ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer.
Bal CS; Kumar A; Pant GS
Nucl Med Commun; 2003 Feb; 24(2):203-8. PubMed ID: 12548045
[TBL] [Abstract][Full Text] [Related]
11. Well-differentiated thyroid cancer: Thyroidectomy or lobectomy?
Kluijfhout WP; Rotstein LE; Pasternak JD
CMAJ; 2016 Dec; 188(17-18):E517-E520. PubMed ID: 27672227
[No Abstract] [Full Text] [Related]
12. Post-surgical thyroid ablation in intermediate risk-differentiated thyroid cancer patients.
Rosario PW
Eur J Endocrinol; 2013 Nov; 169(5):L1. PubMed ID: 24084443
[No Abstract] [Full Text] [Related]
13. [Is our treatment of well-differentiated thyroid cancer too aggressive? Hemithyroidectomy versus total thyroidectomy].
Bongers PJ; Kluijfhout WP; Vriens MW; Mastboom WJ; Lutke Holzik MF
Ned Tijdschr Geneeskd; 2017; 161():D1852. PubMed ID: 29171373
[TBL] [Abstract][Full Text] [Related]
14. Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer.
Mandel SJ; Shankar LK; Benard F; Yamamoto A; Alavi A
Clin Nucl Med; 2001 Jan; 26(1):6-9. PubMed ID: 11139058
[TBL] [Abstract][Full Text] [Related]
15. Reply to letter: Post-surgical thyroid ablation in intermediate risk-differentiated thyroid cancer patients.
Pacini F
Eur J Endocrinol; 2013 Nov; 169(5):L2. PubMed ID: 24084444
[No Abstract] [Full Text] [Related]
16. Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinoma.
Lee HJ; Rha SY; Jo YS; Kim SM; Ku BJ; Shong M; Kim YK; Ro HK
Am J Clin Oncol; 2007 Feb; 30(1):63-8. PubMed ID: 17278897
[TBL] [Abstract][Full Text] [Related]
17. Stunning with 131I diagnostic whole-body imaging of patients with thyroid cancer.
Gerard SK; Dam HQ
Radiology; 2005 Mar; 234(3):972-3; author reply 973-4. PubMed ID: 15734947
[No Abstract] [Full Text] [Related]
18. [Treatment of differentiated thyroid cancer. Management of invasive cancer].
Squifflet JP
Ann Endocrinol (Paris); 1997; 58(3):225-8. PubMed ID: 9239245
[No Abstract] [Full Text] [Related]
19. [Cancer of the thyroid gland].
Biancalana L
Minerva Med; 1968 Apr; 59(32):1857-63. PubMed ID: 5653963
[No Abstract] [Full Text] [Related]
20. Survival of differentiated thyroid carcinoma studied in 500 patients.
Lerch H; Schober O; Kuwert T; Saur HB
J Clin Oncol; 1997 May; 15(5):2067-75. PubMed ID: 9164219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
